黏液层损伤：炎症性肠病（IBD）和肠易激综合征（IBS）可能共同的关键病因。 - Suppr

Suppr

超能文献

Damage of the Mucus Layer: The Possible Shared Critical Common Cause for Both Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS).

作者信息

Qin Xiaofa

机构信息

GI Biopharma Inc., Westfield, New Jersey.

出版信息

Inflamm Bowel Dis. 2017 Feb;23(2):E11-E12. doi: 10.1097/MIB.0000000000001010.

DOI:10.1097/MIB.0000000000001010

PMID:28079624

Abstract

摘要

相似文献

Damage of the Mucus Layer: The Possible Shared Critical Common Cause for Both Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS).黏液层损伤：炎症性肠病（IBD）和肠易激综合征（IBS）可能共同的关键病因。

Inflamm Bowel Dis. 2017 Feb;23(2):E11-E12. doi: 10.1097/MIB.0000000000001010.

Comparison of geographic distributions of Irritable Bowel Syndrome with Inflammatory Bowel Disease fail to support common evolutionary roots: Irritable Bowel Syndrome and Inflammatory Bowel Diseases are not related by evolution.肠易激综合征和炎症性肠病的地理分布比较不能支持共同的进化根源：肠易激综合征和炎症性肠病在进化上没有关系。

Med Hypotheses. 2018 Jan;110:31-37. doi: 10.1016/j.mehy.2017.10.020. Epub 2017 Nov 2.

The functional-organic dichotomy: postinfectious irritable bowel syndrome and inflammatory bowel disease-irritable bowel syndrome.功能-器质性二分法：感染后肠易激综合征与炎症性肠病-肠易激综合征

Clin Gastroenterol Hepatol. 2009 Jan;7(1):48-53. doi: 10.1016/j.cgh.2008.08.032. Epub 2008 Sep 3.

Stigmatization toward irritable bowel syndrome and inflammatory bowel disease in an online cohort.在线队列中对肠易激综合征和炎症性肠病的污名化

Neurogastroenterol Motil. 2017 Feb;29(2). doi: 10.1111/nmo.12921. Epub 2016 Aug 8.

Is irritable bowel syndrome a low-grade inflammatory bowel disease?肠易激综合征是一种低度炎症性肠病吗？

Gastroenterol Clin North Am. 2005 Jun;34(2):235-45, vi-vii. doi: 10.1016/j.gtc.2005.02.007.

Elevated serum chromogranin A in irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD): a shared model for pathogenesis?肠易激综合征（IBS）和炎症性肠病（IBD）中血清嗜铬粒蛋白A升高：发病机制的共同模型？

Inflamm Bowel Dis. 2010 Mar;16(3):361. doi: 10.1002/ibd.20982.

The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome?曼尼托巴炎症性肠病队列研究：诊断前的长期症状——肠易激综合征占多少比例？

Clin Gastroenterol Hepatol. 2006 May;4(5):614-20. doi: 10.1016/j.cgh.2006.03.003. Epub 2006 Apr 17.

Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.炎症性肠病-肠易激综合征在CCFA合作伙伴中对患者报告结局的患病率及影响

Inflamm Bowel Dis. 2017 Feb;23(2):325-331. doi: 10.1097/MIB.0000000000001017.

Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity.炎症性肠病患者肠易激综合征的症状：探讨亚临床炎症的作用及其对疾病活动临床评估的影响。

Aliment Pharmacol Ther. 2013 Jul;38(1):44-51. doi: 10.1111/apt.12335. Epub 2013 May 13.

'I feel as if my IBS is keeping me hostage!' Exploring the negative impact of irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) upon university-aged women.“我感觉我的肠易激综合征把我困住了！”探究肠易激综合征（IBS）和炎症性肠病（IBD）对大学年龄段女性的负面影响。

Int J Nurs Pract. 2008 Apr;14(2):135-48. doi: 10.1111/j.1440-172X.2008.00677.x.

引用本文的文献

The Role of Gut Microbiome in Irritable Bowel Syndrome: Implications for Clinical Therapeutics.肠道微生物群在肠易激综合征中的作用：对临床治疗的启示

Biomolecules. 2024 Dec 21;14(12):1643. doi: 10.3390/biom14121643.

Activation of goblet cell Piezo1 alleviates mucus barrier damage in mice exposed to WAS by inhibiting H3K9me3 modification.杯状细胞Piezo1的激活通过抑制H3K9me3修饰减轻暴露于黄蜂毒液的小鼠的黏液屏障损伤。

Cell Biosci. 2023 Jan 12;13(1):7. doi: 10.1186/s13578-023-00952-5.

Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome: Jejunal Barrier Alterations Underlying Clinical Manifestations.黏膜浆细胞激活和靠近神经纤维与腹泻为主的肠易激综合征中的糖萼减少有关：潜在临床表现的空肠屏障改变。

Cells. 2022 Jun 28;11(13):2046. doi: 10.3390/cells11132046.

A Network Pharmacology-Based Study on Irritable Bowel Syndrome Prevention and Treatment Utilizing Shenling Baizhu Powder.基于网络药理学的参苓白术散防治肠易激综合征的研究。

Biomed Res Int. 2021 Nov 23;2021:4579850. doi: 10.1155/2021/4579850. eCollection 2021.

Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome.口服纳米医学调节免疫、肠道屏障功能和肠道微生物组。

Adv Drug Deliv Rev. 2021 Dec;179:114021. doi: 10.1016/j.addr.2021.114021. Epub 2021 Oct 26.

Dairy Propionibacterium freudenreichii ameliorates acute colitis by stimulating MUC2 expression in intestinal goblet cell in a DSS-induced colitis rat model.干酪乳杆菌丙酸通过刺激 DSS 诱导的结肠炎大鼠模型肠杯状细胞中 MUC2 的表达来改善急性结肠炎。

Sci Rep. 2020 Mar 26;10(1):5523. doi: 10.1038/s41598-020-62497-8.

Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives.纳米颗粒介导的药物传递系统治疗炎症性肠病：当前的观点。

Int J Nanomedicine. 2019 Nov 13;14:8875-8889. doi: 10.2147/IJN.S210315. eCollection 2019.

Metabolomics reveals elevated urinary excretion of collagen degradation and epithelial cell turnover products in irritable bowel syndrome patients.代谢组学揭示了肠易激综合征患者尿液中胶原降解和上皮细胞更替产物的排泄增加。

Metabolomics. 2019 May 20;15(6):82. doi: 10.1007/s11306-019-1543-0.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验